MR Solutions' new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs.

MR Solutions will be displaying its latest cryogen free 3T and 7T preclinical, multi-modality MRI models to the imaging science community

MR Solutions and Summit Pharmaceuticals have reached an agreement where Summit Pharmaceuticals will be the sole supplier for MR Solutions' preclinical, multi-modality cryogen free MRI imaging systems to the Japanese market.

PET and MRI preclinical imaging systems can now be operated simultaneously for the first time by researchers.

MR Solutions, of Guildford, UK, will be exhibiting its preclinical imaging systems at the International Society for Magnetic Resonance in Medicine (ISMRM), in Toronto, from 30 May to 5 June, 2015.